| The consensus coding sequences of human breast and colorectal cancers | Science | 2006 | 2.8K |
| Estrogen carcinogenesis in breast cancer | New England Journal of Medicine | 2006 | 1.3K |
| Cancer's molecular sweet tooth and the Warburg effect | Cancer Research | 2006 | 954 |
| The c-Myc target gene network | Seminars in Cancer Biology | 2006 | 806 |
| The colorectal microRNAome | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 797 |
| Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer | PLoS Medicine | 2006 | 745 |
| Hyaluronan fragments act as an endogenous danger signal by engaging TLR2 | Journal of Immunology | 2006 | 529 |
| Global mapping of c-Myc binding sites and target gene networks in human B cells | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 411 |
| Oncogenic PI3K and its role in cancer | Current Opinion in Oncology | 2006 | 399 |
| Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment | Clinical Pharmacology and Therapeutics | 2006 | 376 |
| Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity | Nature Medicine | 2006 | 345 |
| Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation | PLoS Genetics | 2006 | 320 |
| Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide | Biochemical and Biophysical Research Communications | 2006 | 272 |
| Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells | Stem Cells | 2006 | 259 |
| BEAMing up for detection and quantification of rare sequence variants | Nature Methods | 2006 | 219 |
| Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth | American Journal of Pathology | 2006 | 131 |
| Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells | Cancer Research | 2006 | 124 |
| Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 115 |
| Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer | Cancer Research | 2006 | 108 |
| The role of companion diagnostics in the development and use of mutation-targeted cancer therapies | Nature Biotechnology | 2006 | 108 |
| A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC) | Journal of Clinical Oncology | 2006 | 106 |
| The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT | Nature Biotechnology | 2006 | 105 |
| Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib | Clinical Pharmacology and Therapeutics | 2006 | 105 |
| Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 95 |
| Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells | Biochemical Journal | 2006 | 86 |
